Top news
COVID-19 vaccines for children and teens: What we do — and don't — know
By Kristin Leigh Moffitt
Why we shouldn't panic about the millions who missed their second vaccine dose—yet
By Maya Wei-Haas
India's vaccinations plummet as coronavirus infections soar
By Krishna N. Das
Posts on X
Formerly TwitterTedros Adhanom Ghebreyesus
DrTedros
#WorldImmunizationWeek 2024 ended, but our work to reach every last child with life-saving vaccines doesn’t, because no one deserves to die from a preventable illness.
Together we can show what’s #HumanlyPossible.
pic.twitter.com/rGDGV1qidc
Posted on X
Ministry of Health
MoHFW_INDIA
Unlock the shield of protection with the Universal Immunization Program! Safeguard yourself against 12 vaccine-preventable diseases, absolutely free. From diphtheria to Japanese Encephalitis, we've got you covered.
.
.
#WorldImmunizationWeek pic.twitter.com/GjKXg8b1YE
Posted on X
World Health Organization (WHO)
WHO
Governments, aid agencies, thousands of people –– from scientists to health workers to volunteers –– got us to where we are today.
Vaccines have kept us all healthy and safe. They’ve made everything in our lives possible.
Show us what you’re made of.
Show us your possible.… pic.twitter.com/6hmNmBoZLS
Posted on X
World Health Organization (WHO)
WHO
154 million lives saved through #immunization.
That’s 6 lives a minute for 5 decades.
Amazing.
And though you probably don’t remember the exact moment you were immunized, you’re part of this incredible achievement. Now we need your help again. Tell leaders to invest in vaccines… pic.twitter.com/BsFCKRrkiy
Posted on X
All coverage
Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues
By Kevin Breuninger
Pfizer Seeks Full FDA Approval For COVID-19 Vaccine
By Emma Bowman
BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says
By Noah Higgins-Dunn
How the Moderna, AstraZeneca, Pfizer and other Covid vaccines compare
By Annelies Gartner, Anne Gulland & Lizzie Roberts
Pfizer-BioNTech Vaccine is Highly Effective Against Variants, Studies Find (Published 2021)
By Emily Anthes
Pfizer to seek authorization for Covid-19 vaccine for children ages 2 to 11 in September
By Naomi Thomas
FDA preparing to authorize Pfizer Covid vaccine for 12- to 15-year-olds as early as next week
By Lauren Egan & Laura Strickler
Pfizer sees robust COVID-19 vaccine demand for years, $26 bln in 2021 sales
By Michael Erman & Manas Mishra
BioNTech nearing request for approval of longer-lasting version of COVID vaccine
By Louise Heavens, Ludwig Burger & Alistair Smout
U.S. FDA set to authorize Pfizer COVID-19 shot for ages 12-15 early next week - NYT
By Trisha Roy & Devika Syamnath
Pfizer and BioNTech begin the process of seeking full U.S. approval for their Covid vaccine
By Berkeley Lovelace, Berkeley Lovelace Jr. & Dawn Kopecki
Poll Shows Parents Are Reluctant to Get Their Children Vaccinated for Covid-19 (Published 2021)
By Jan Hoffman
Covid-19: F.D.A. to Authorize Pfizer Vaccine for Adolescents by Early Next Week (Published 2021)
By Apoorva Mandavilli, Kate Taylor & Will Wright
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine (Published 2021)
By Rebecca Robbins & Peter S. Goodman
COVID-19 vaccines and kids: What parents should know
By Katie Kindelan